Medicenna Therapeutics announced the appointment of Humphrey Gardner, M.D., as Chief Medical Officer, CMO, to lead the development strategy and execution of Medicenna’s clinical programs. Dr. Gardner’s career in the biopharmaceutical industry spans over two decades. Most recently, Dr. Gardner served as CMO at Harbour BioMed advancing novel antibody and bispecific therapeutics in oncology.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDNA:
- Medicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officer
- Medicenna Therapeutics presents preclinical MDNA223 BiSKIT data
- Medicenna Announces Results of Annual and Special Meeting of Shareholders
- Medicenna to Present at the AACR Special Conference Cancer Research: Tumor Immunology and Immunotherapy
- Medicenna Therapeutics appoints Jeff Caravella as CFO